425 related articles for article (PubMed ID: 18616411)
1. Novel biologic mechanisms of levosimendan and its effect on the failing heart.
Parissis JT; Andreadou I; Bistola V; Paraskevaidis I; Filippatos G; Kremastinos DT
Expert Opin Investig Drugs; 2008 Aug; 17(8):1143-50. PubMed ID: 18616411
[TBL] [Abstract][Full Text] [Related]
2. Levosimendan: from basic science to clinical practice.
Parissis JT; Rafouli-Stergiou P; Paraskevaidis I; Mebazaa A
Heart Fail Rev; 2009 Dec; 14(4):265-75. PubMed ID: 19101796
[TBL] [Abstract][Full Text] [Related]
3. The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure.
Cavusoglu Y
Expert Opin Pharmacother; 2007 Apr; 8(5):665-77. PubMed ID: 17376021
[TBL] [Abstract][Full Text] [Related]
4. Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure.
Kivikko M; Lehtonen L
Curr Pharm Des; 2005; 11(4):435-55. PubMed ID: 15725064
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic treatment of heart failure due to ventricular dysfunction by myocardial stunning: potential role of levosimendan.
García González MJ; Domínguez Rodríguez A
Am J Cardiovasc Drugs; 2006; 6(2):69-75. PubMed ID: 16555860
[TBL] [Abstract][Full Text] [Related]
6. Levosimendan: beyond its simple inotropic effect in heart failure.
Antoniades C; Tousoulis D; Koumallos N; Marinou K; Stefanadis C
Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
[TBL] [Abstract][Full Text] [Related]
7. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
Follath F
Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
[TBL] [Abstract][Full Text] [Related]
8. Levosimendan, a new calcium-sensitizing inotrope for heart failure.
Ng TM
Pharmacotherapy; 2004 Oct; 24(10):1366-84. PubMed ID: 15628834
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory and anti-apoptotic effects of levosimendan in decompensated heart failure: a novel mechanism of drug-induced improvement in contractile performance of the failing heart.
Paraskevaidis IA; Parissis JT; Th Kremastinos D
Curr Med Chem Cardiovasc Hematol Agents; 2005 Jul; 3(3):243-7. PubMed ID: 15974888
[TBL] [Abstract][Full Text] [Related]
10. Levosimendan: A promising agent for the treatment of hospitalized patients with decompensated heart failure.
Lehtonen L
Curr Cardiol Rep; 2000 May; 2(3):233-43. PubMed ID: 10980898
[TBL] [Abstract][Full Text] [Related]
11. Levosimendan for Perioperative Cardioprotection: Myth or Reality?
Santillo E; Migale M; Massini C; Incalzi RA
Curr Cardiol Rev; 2018; 14(3):142-152. PubMed ID: 29564979
[TBL] [Abstract][Full Text] [Related]
12. Levosimendan: a novel agent in heart failure.
Koumallos N; Antoniades C; Tousoulis D; Shirodaria C; Stefanadis C
Recent Pat Cardiovasc Drug Discov; 2006 Jun; 1(2):185-91. PubMed ID: 18221085
[TBL] [Abstract][Full Text] [Related]
13. Inoprotection: the perioperative role of levosimendan.
Soeding PE; Royse CF; Wright CE; Royse AG; Angus JA
Anaesth Intensive Care; 2007 Dec; 35(6):845-62. PubMed ID: 18084975
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the pharmacokinetics of levosimendan and its effects on cardiovascular system.
Antoniades C; Antonopoulos AS; Tousoulis D; Bakogiannis C; Stefanadi E; Stefanadis C
Curr Drug Metab; 2009 Feb; 10(2):95-103. PubMed ID: 19275545
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects.
Pathak A; Lebrin M; Vaccaro A; Senard JM; Despas F
J Clin Pharm Ther; 2013 Oct; 38(5):341-9. PubMed ID: 23594161
[TBL] [Abstract][Full Text] [Related]
16. Levosimendan, a new inotropic and vasodilator agent.
Toller WG; Stranz C
Anesthesiology; 2006 Mar; 104(3):556-69. PubMed ID: 16508404
[TBL] [Abstract][Full Text] [Related]
17. Levosimendan: a new option in acute cardiac failure.
Holley AD; Ziegenfuss M
Emerg Med Australas; 2006; 18(5-6):505-9. PubMed ID: 17083641
[No Abstract] [Full Text] [Related]
18. Calcium sensitization as new principle of inotropic therapy in end-stage heart failure?
Zimmermann N; Boknik P; Gams E; Herzig JW; Neumann J; Scholz H
Eur J Cardiothorac Surg; 1998 Jul; 14(1):70-5. PubMed ID: 9726618
[TBL] [Abstract][Full Text] [Related]
19. European experience on the practical use of levosimendan in patients with acute heart failure syndromes.
Follath F; Franco F; Cardoso JS
Am J Cardiol; 2005 Sep; 96(6A):80G-5G. PubMed ID: 16181827
[TBL] [Abstract][Full Text] [Related]
20. Levosimendan.
Figgitt DP; Gillies PS; Goa KL
Drugs; 2001; 61(5):613-27; discussion 628-9. PubMed ID: 11368286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
